Janssen-Cilag Ltd.
Quick facts
Marketed products
- Risperidone prolonged release
- TMC114/ritonavir · Infectious Disease
TMC114 (darunavir) is a protease inhibitor that blocks HIV protease, preventing viral replication when boosted with ritonavir.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Janssen-Cilag Ltd.
What are Janssen-Cilag Ltd.'s marketed drugs?
Top marketed products include Risperidone prolonged release, TMC114/ritonavir.
Related
- Risperidone prolonged release
- TMC114/ritonavir · Infectious Disease
- Sector hub: All tracked pharma companies